Boston Scientific vs Cardinal Health

Boston Scientific (BSX), health care, and Cardinal Health (CAH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Cardinal Health is worth $65.4B on the stock market and Boston Scientific $62.6B: Cardinal Health is valued at 4% more. Boston Scientific trades at 18.2 times earnings and Cardinal Health at 36.6; operating margins in their latest fiscal years were 18.0% and 1.03%. Over the past year Boston Scientific's share price has moved -56.0% and Cardinal Health's +37.1%.

Key facts

Boston Scientific market value
$62.6B
Cardinal Health market value
$65.4B
Boston Scientific P/E
18.2
Cardinal Health P/E
36.6
Boston Scientific revenue
$20.1BFY to 2025-12-31
Cardinal Health revenue
$254.2BFY to 2026-06-30
Superinvestors holding both
1

Market values as of .

Boston Scientific vs Cardinal Health: every measure side by side
Measure Boston Scientific Cardinal Health
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312026-06-30
Size
Market cap$62.6Blower$65.4Bhigher
Revenue$20.1Blower$254.2Bhigher
Earnings$2.9Bhigher$1.7Blower
Employees59,000higher58,788lower
Total assets$43.7Blower$57.3Bhigher
Valuation
P/E18.2lower36.6higher
P/S3.1higher0.3lower
P/B2.4—
Dividend yield0.00%lower0.72%higher
Profitability
Operating margin18.0%higher1.03%lower
Balance sheet
Net assets$24.2Bhigher-$2.9Blower
Total liabilities$19.2Blower$60Bhigher
Total debt$11.4Bhigher$8.9Blower
Cash on hand$2Blower$4.9Bhigher
Price change
Today-1.09%lower-0.36%higher
1 year-56.0%lower+37.1%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Boston Scientific / Cardinal Health). Who owns BSX · Who owns CAH

Further comparisons

Learn

Questions and answers

Which is bigger, Boston Scientific or Cardinal Health?

By market value, Cardinal Health is the larger: $65.4B against $62.6B for Boston Scientific. By revenue in its latest fiscal year, Cardinal Health is the larger: $254.2B against $20.1B for Boston Scientific.

Which has the higher P/E ratio?

Cardinal Health: 36.6, against 18.2 for Boston Scientific. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Boston Scientific: 18.0%, against 1.03% for Cardinal Health. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Cardinal Health: 0.72%, against 0.00% for Boston Scientific. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Boston Scientific: $11.4B, against $8.9B for Cardinal Health. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Boston Scientific and Cardinal Health?

In their latest 13F filings, Larry Robbins holds both.

Cite this page

Funkfolio, “Boston Scientific vs Cardinal Health”, data as of 17 November 2026. https://funkfolio.com/compare/bsx-vs-cah

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.